Trials / Completed
CompletedNCT00613652
A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients
A Phase I, Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 Administered Weekly in Japanese Adult Patients With Advanced Solid Malignancies
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to evaluate the safety and tolerability of AZD4877 on a weekly schedule in Japanese patients with advanced solid malignancies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AZD4877 | 10 mg IV (3 weeks treatment 1 week rest) |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2008-02-13
- Last updated
- 2009-07-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00613652. Inclusion in this directory is not an endorsement.